Barclays raised the firm’s price target on ASML (ASML) to EUR 570 from EUR 550 and keeps an Overweight rating on the shares. The firm expects the narrative for ASML to be challenged near term given its weaker 2025 guidance ahead of the Q3 report. However, following the results, the company’s outlook will improve with content growth ahead, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASML:
- ASML upgraded to Outperform from Neutral at Mizuho
- European Stocks: Our AI Analyst Puts on Its Golfing Plus Fours and Picks RELX, ASML, ESEA
- How Will a Trump 1:1 Chip Production Tariff Policy Play Out?
- Video: Metsera jumps after Pfizer strikes deal for obesity drugmaker
- ASML upgraded to Buy from Hold at Erste Group